GAROFALO ELIZABETH A.

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GAROFALO ELIZABETH A.'s trades of ACADIA Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
392.28
Quantity 73,517
Value US$1,604,025
Transaction date
Sale
Price
99.86
Quantity 13,588 +34.3%
Value US$546,786
Transaction date
Sale
Price
45.69
Quantity 2,092 -100.0%
Value US$95,583
Transaction date
Proposed sale
Price
45.69
Quantity 2,092
Value US$95,574
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-03 2025-09-02
S Sale
66,344 +7.0%
184.64
US$4,480,235 		66,344 +7.0% 184.64 US$4,480,235
2025-03-06 2025-03-05
PrS Proposed sale
73,517
392.28
US$1,604,025 		73,517 392.28 US$1,604,025
2025-03-06 2025-03-05
S Sale
13,588 +34.3%
99.86
US$546,786 		13,588 +34.3% 99.86 US$546,786
2024-03-11 2024-03-08
S Sale
2,092 -100.0%
45.69
US$95,583 		2,092 -100.0% 45.69 US$95,583
2024-03-08 2024-03-08
PrS Proposed sale
2,092
45.69
US$95,574 		2,092 45.69 US$95,574